UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide

Journal of controlled release, 2019-11, Vol.314, p.102-115

2019

Volltextzugriff (PDF)

Dry Powder Formulation of Plasmid DNA and siRNA for Inhalation

Current pharmaceutical design, 2015-01, Vol.21 (27), p.3854

2015

Volltextzugriff (PDF)

Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery

Asian journal of pharmceutical sciences, 2018-03, Vol.13 (2), p.163-172

2018

Volltextzugriff (PDF)

Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids

European journal of pharmaceutics and biopharmaceutics, 2014-01, Vol.86 (1), p.64-73

2014

Volltextzugriff (PDF)

Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways

Journal of controlled release, 2012-03, Vol.158 (2), p.293-303

2012

Volltextzugriff (PDF)

Inhaled RNA Therapy: From Promise to Reality

Trends in pharmacological sciences (Regular ed.), 2020-10, Vol.41 (10), p.715-729

2020

Volltextzugriff (PDF)

Dry powder pharmaceutical biologics for inhalation therapy

Advanced drug delivery reviews, 2021-05, Vol.172, p.64-79

2021

Volltextzugriff (PDF)

Inhalation delivery technology for genome-editing of respiratory diseases

Advanced drug delivery reviews, 2021-01, Vol.168, p.217-228

2021

Volltextzugriff (PDF)

siRNA Versus miRNA as Therapeutics for Gene Silencing

Molecular therapy. Nucleic acids, 2015-09, Vol.4 (9), p.e252-e252, Article e252

2015

Volltextzugriff (PDF)

Modeling of a spray drying method to produce ciprofloxacin nanocrystals inside the liposomes utilizing a response surface methodology: Box-Behnken experimental design

International journal of pharmaceutics, 2021-03, Vol.597, p.120277-120277, Article 120277

2021

Volltextzugriff (PDF)

Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis

Pharmaceutical research, 2023-05, Vol.40 (5), p.1073-1086

2023

Volltextzugriff (PDF)

Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation—A proof-of-principle study in a P. aeruginosa lung infection model

European journal of pharmaceutics and biopharmaceutics, 2021-01, Vol.158, p.166-171

2021

Volltextzugriff (PDF)

The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice

Clinical microbiology and infection, 2022-07, Vol.28 (7), p.983-989

2022

Volltextzugriff (PDF)

Inhalable neutralizing antibodies – promising approach to combating respiratory viral infections

Trends in pharmacological sciences (Regular ed.), 2023-02, Vol.44 (2), p.85-97

2023

Volltextzugriff (PDF)

Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition

International journal of pharmaceutics, 2019-04, Vol.560, p.144-154

2019

Volltextzugriff (PDF)

A dual action of D-amino acids on anti-biofilm activity and moisture-protection of inhalable ciprofloxacin powders

European journal of pharmaceutics and biopharmaceutics, 2022-04, Vol.173, p.132-140

2022

Volltextzugriff (PDF)

Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation

International journal of pharmaceutics, 2018-12, Vol.552 (1-2), p.67-75

2018

Volltextzugriff (PDF)

Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic

Advanced drug delivery reviews, 2020-01, Vol.160, p.234-243

2020

Volltextzugriff (PDF)

Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer

International journal of pharmaceutics, 2017-09, Vol.530 (1-2), p.40-52

2017

Volltextzugriff (PDF)

Predicting the composition and size distribution of dry particles for aerosols and sprays of suspension: A Monte Carlo approach

International journal of pharmaceutics, 2020-05, Vol.582, p.119311-119311, Article 119311

2020

Volltextzugriff (PDF)

High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin

International journal of pharmaceutics, 2019-12, Vol.572, p.118818-118818, Article 118818

2019

Volltextzugriff (PDF)

Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19

Journal of aerosol medicine and pulmonary drug delivery, 2021-02, Vol.34 (1), p.20

2021

Volltextzugriff (PDF)

From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery

Molecular pharmaceutics, 2017-12, Vol.14 (12), p.4606-4617

2017

Volltextzugriff (PDF)

Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis

International journal of pharmaceutics, 2015-08, Vol.491 (1-2), p.367-374

2015

Volltextzugriff (PDF)

Potential and development of inhaled RNAi therapeutics for the treatment of pulmonary tuberculosis

Advanced drug delivery reviews, 2016-07, Vol.102, p.21-32

2016

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Pharmacology & Pharmacy
(25)
Pulmonary Delivery
(14)
Humans
(13)
Administration, Inhalation
(11)
Spray Drying
(11)
Particle Size
(9)
Inhalation
(8)
Powders
(8)
Small Interfering Rna
(7)
Aerosols
(6)
Dry Powder Inhalers
(6)
Gene Silencing
(6)
Spray Freeze Drying
(6)
Chemistry, Pharmaceutical
(5)
Rna, Small Interfering - Administration & Dosage
(5)
Sirna
(4)
Tuberculosis
(4)
Aerosol
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide

Dry Powder Formulation of Plasmid DNA and siRNA for Inhalation

Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery

Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids

Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways

Inhaled RNA Therapy: From Promise to Reality

Dry powder pharmaceutical biologics for inhalation therapy

Inhalation delivery technology for genome-editing of respiratory diseases

siRNA Versus miRNA as Therapeutics for Gene Silencing

Modeling of a spray drying method to produce ciprofloxacin nanocrystals inside the liposomes utilizing a response surface methodology: Box-Behnken experimental design

Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis

Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation—A proof-of-principle study in a P. aeruginosa lung infection model

The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice

Inhalable neutralizing antibodies – promising approach to combating respiratory viral infections

Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition

A dual action of D-amino acids on anti-biofilm activity and moisture-protection of inhalable ciprofloxacin powders

Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation

Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic

Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer

Predicting the composition and size distribution of dry particles for aerosols and sprays of suspension: A Monte Carlo approach

High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin

Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19

From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery

Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis

Potential and development of inhaled RNAi therapeutics for the treatment of pulmonary tuberculosis

Suchergebnisse filtern